Biomarker Jeopardy

Sandra E Kurtin,Alyssa Henglefelt,Haleigh Mistry
DOI: https://doi.org/10.6004/jadpro.2022.13.3.22
Abstract:In the popular Biomarker Jeopardy session, Sandra E. Kurtin, PhD, ANP-C, AOCN®, Alyssa Henglefelt, PharmD, BCOP, and Haleigh Mistry, MS, PA-C, paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and discussed guidelines for biomarker testing.
What problem does this paper attempt to address?